Michael Scott Salka

AmpliPhi Biosciences

former Chief Executive Officer

Overview

Michael Scott Salka made an average of $1.7M in compensation at AmpliPhi Biosciences from 2015 to 2017.

Annual data

2017

In 2017, Michael Scott Salka earned a total compensation of $704.4K as former Chief Executive Officer at AmpliPhi Biosciences.

Ranking9,951 out of 13,725
Percentile27.5%

Michael Scott Salka's 2017 compensation ranked 9,951st out of 13,725 executive pay records tracked by us this year.

Salka earned more than 27.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,099 out of 1,553
Percentile29.2%

In the industry group of Drugs, Salka's pay ranked 1,099th out of 1,553 executive pay records tracked by us in 2017.

Salka earned more than 29.2% of executives in this group.

Non-Equity Incentive Plan$144,051
Option Awards$84,693
Salary$227,769
Other$247,917
Total$704,430

Salka received $247.9K in other compensation, which accounts for 35.19% of total compensation.

Salka also received $144.1K in non-equity incentive plan, $84.7K in option awards and $227.8K in salary.

2016

In 2016, Michael Scott Salka earned a total compensation of $528K as Chief Executive Officer at AmpliPhi Biosciences.

Ranking10,950 out of 14,026
Percentile21.9%

Michael Scott Salka's 2016 compensation ranked 10,950th out of 14,026 executive pay records tracked by us this year.

Salka earned more than 21.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,198 out of 1,495
Percentile19.9%

In the industry group of Drugs, Salka's pay ranked 1,198th out of 1,495 executive pay records tracked by us in 2016.

Salka earned more than 19.9% of executives in this group.

Non-Equity Incentive Plan$102,000
Salary$425,000
Other$988
Total$527,988

Salka received $425K in salary, which accounts for 80.49% of total compensation.

Salka also received $102K in non-equity incentive plan and $988 in other compensation.

2015

In 2015, Michael Scott Salka earned a total compensation of $3.8M as Chief Executive Officer at AmpliPhi Biosciences.

Ranking2,302 out of 13,577
Percentile83.0%

Michael Scott Salka's 2015 compensation ranked 2,302nd out of 13,577 executive pay records tracked by us this year.

Salka earned more than 83.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking232 out of 1,485
Percentile84.4%

In the industry group of Drugs, Salka's pay ranked 232nd out of 1,485 executive pay records tracked by us in 2015.

Salka earned more than 84.4% of executives in this group.

Non-Equity Incentive Plan$85,000
Option Awards$3,469,919
Salary$264,263
Other$364
Total$3,819,546

Salka received $3.5M in option awards, which accounts for 90.85% of total compensation.

Salka also received $85K in non-equity incentive plan, $264.3K in salary and $364 in other compensation.